Online citations, reference lists, and bibliographies.
← Back to Search

Dry Tablet Formulation Of PLGA Nanoparticles With A Preocular Applicator For Topical Drug Delivery To The Eye

Woo Mi Ryu, Se-na Kim, C. H. Min, Y. Choy
Published 2019 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
To enhance ocular drug bioavailability, a rapidly dissolving dry tablet containing alginate and drug-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles was proposed. For hygienic and easy administration of an accurate drug-dose with this tablet, the use of a preocular applicator was suggested. Herein, a dry tablet was prepared by embedding dexamethasone-loaded PLGA nanoparticles in alginate, which was deposited on the tip of the applicator. The nanoparticles were loaded with 85.45 μg/mg drug and exhibited sustained drug release for 10 h. To evaluate in vivo efficacy, dexamethasone concentration in the aqueous humor was measured after topical administration of the dry tablet, with the applicator, to rabbit eyes and was compared to that achieved with Maxidex®, a commercially-available dexamethasone eye drops. When applied with the preocular applicator, the dry tablet containing alginate could be fully detached and delivered to the eye surface. In fact, it showed up to 2 h of nanoparticle retention on the preocular surface due to tear viscosity enhancement, causing an estimated 2.6-fold increase in ocular drug bioavailability compared to Maxidex®. Therefore, the preocular applicator combined with a dry alginate tablet containing PLGA nanoparticles can be a promising system for aseptically delivering an accurate dose of ophthalmic drug with enhanced bioavailability.
This paper references
Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E.
J. Kim (2010)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
The composition and interfacial properties of tears, tear substitutes and tear models
Anne M. Bright (1993)
Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
H. Sigurdsson (2007)
Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
J. Rodríguez Villanueva (2016)
Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis.
R. Graham (1974)
Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
D. Tan (1999)
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
R. Jain (2000)
Ocular drug delivery conventional ocular formulations
John C. Lang (1995)
Novel approaches to ocular drug delivery.
J. Davis (2004)
Blinking and the mechanics of the lacrimal drainage system.
M. Doane (1981)
Ocular absorption following topical delivery
K. Jaervinen (1995)
Contact lens hygiene compliance in a universitypopulation
C. Radford (1993)
Contact lenses and other risk factors in microbial keratitis
J. Dart (1991)
Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
Cheng-Han Tsai (2018)
Nanomedicines for ocular NSAIDs: safety on drug delivery.
J. Araújo (2009)
Refresh . REFRESH ® Classic
R. O. Graham
DNA amplification with in situ nucleoside to dNTP synthesis, using a single recombinant cell lysate of E. coli
Thomas D Loan (2019)
Molecular basis of C(2+)-induced gelation in alginates and pectins: the egg-box model revisited.
I. Braccini (2001)
Alginate based new materials.
K. Draget (1997)
Relevance of Rheological Properties of Sodium Alginate in Solution to Calcium Alginate Gel Properties
S. Fu (2011)
Mucoadhesive microparticles in a rapidly dissolving tablet for sustained drug delivery to the eye.
Y. Choy (2011)
Joining the un-joinable: adhesion between low surface energy polymers using tetrapodal ZnO linkers.
X. Jin (2012)
A Mathematical Model for Ocular Tear and Solute Balance
H. Zhu (2005)
The tear turnover and tear clearance tests – a review
I. K. Garaszczuk (2018)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.
Hirenkumar K. Makadia (2011)
Novel approaches to ocular drug
J. Davis (2004)
Metal-organic frameworks, NH2-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine.
Se-na Kim (2018)
Mucoadhesive Microparticles Engineered for Ophthalmic Drug Delivery.
Young Bin Choy (2008)
Nanostructured Mucoadhesive Microparticles for Enhanced Preocular Retention
박천권 (2013)
Topical ocular drug delivery: recent developments and future challenges.
V. Lee (1986)
A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration
Changling Sun (2015)
Biodegradable Implants for Sustained Drug Release in the Eye
S. Lee (2010)
FreeZone 6 Liter - 84 C Console Freeze Dryer
T. Loan
Nanomedicines for ocular NSAIDs
J. Araújo (2009)
FreeZone 6 Liter -84C Console Freeze Dryer
Shelf-Life Evaluation and Lyophilization of PBCA-Based Polymeric Microbubbles
Tarun Ojha (2019)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar